Prevention of Human Papillomavirus and Vaccines Strategies

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Papillomavirus Vaccines".

Deadline for manuscript submissions: 30 May 2024 | Viewed by 352

Special Issue Editor

E-Mail Website
Guest Editor
Inov4Agro—Institute for Innovation, Capacity Building and Sustainability of Agri-Food Production, Universidade Federal do Maranhao, Sao Luis, Brazil
Interests: GU malignancies; papillomavirus-induced pathologies
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues, 

Human papillomavirus (HPV) causes the most common sexually transmissible infection worldwide and is associated with benign and malignant lesions of the ano-genital and head-and-neck regions. The development of HPV vaccines is a success story, leading to marked reductions in the incidence of cervical uterine lesions. However, multiple questions regarding HPV prevention remain unanswered, including which strategies might successfully implement vaccination across culturally heterogeneous communities, the extent of its efficacy in preventing specific lesions, how vaccines might be combined with other preventive strategies, and the potential therapeutic efficacy of HPV vaccines against established lesions. This Special Issue welcomes all kinds of contributions, including original research and review articles, on topics related to HPV prevention and vaccination. We expect this Special Issue to be an opportunity to advance scientific knowledge in this field and encourage more effective HPV approaches.

Prof. Dr. Rui Gil da Costa
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • human papillomavirus
  • HPV vaccines
  • vaccination strategies
  • cervical cancer prevention
  • therapeutic vaccines

Published Papers

This special issue is now open for submission.
Back to TopTop